BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20511291)

  • 1. Development of molecular docking-based binding energy to predict the joint effect of BPA and its analogs.
    Zhang HC; Hu XL; Yin DQ; Lin ZF
    Hum Exp Toxicol; 2011 Apr; 30(4):318-27. PubMed ID: 20511291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency.
    Yoshihara S; Mizutare T; Makishima M; Suzuki N; Fujimoto N; Igarashi K; Ohta S
    Toxicol Sci; 2004 Mar; 78(1):50-9. PubMed ID: 14691209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the mutagenic and estrogenic activities of bisphenol A upon treatment with nitrite.
    Masuda S; Terashima Y; Sano A; Kuruto R; Sugiyama Y; Shimoi K; Tanji K; Yoshioka H; Terao Y; Kinae N
    Mutat Res; 2005 Aug; 585(1-2):137-46. PubMed ID: 15936980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular quantum similarity analysis of estrogenic activity.
    Gallegos Saliner A; Amat L; Carbó-Dorca R; Schultz TW; Cronin MT
    J Chem Inf Comput Sci; 2003; 43(4):1166-76. PubMed ID: 12870908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking of bisphenol A and its nitrated and chlorinated metabolites onto human estrogen-related receptor-gamma.
    Babu S; Vellore NA; Kasibotla AV; Dwayne HJ; Stubblefield MA; Uppu RM
    Biochem Biophys Res Commun; 2012 Sep; 426(2):215-20. PubMed ID: 22935422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute toxicity, mutagenicity, and estrogenicity of biodegradation products of bisphenol-A.
    Ike M; Chen MY; Jin CS; Fujita M
    Environ Toxicol; 2002 Oct; 17(5):457-61. PubMed ID: 12242676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma.
    Okada H; Tokunaga T; Liu X; Takayanagi S; Matsushima A; Shimohigashi Y
    Environ Health Perspect; 2008 Jan; 116(1):32-8. PubMed ID: 18197296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphenol A, an environmental endocrine-disrupting chemical, inhibits hypoxic response via degradation of hypoxia-inducible factor 1alpha (HIF-1alpha): structural requirement of bisphenol A for degradation of HIF-1alpha.
    Kubo T; Maezawa N; Osada M; Katsumura S; Funae Y; Imaoka S
    Biochem Biophys Res Commun; 2004 Jun; 318(4):1006-11. PubMed ID: 15147973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans.
    Elsby R; Maggs JL; Ashby J; Park BK
    J Pharmacol Exp Ther; 2001 Apr; 297(1):103-13. PubMed ID: 11259533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of estrogenic activity of chemicals for the development of new dental polymers.
    Hashimoto Y; Moriguchi Y; Oshima H; Kawaguchi M; Miyazaki K; Nakamura M
    Toxicol In Vitro; 2001; 15(4-5):421-5. PubMed ID: 11566573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume learning algorithm significantly improved PLS model for predicting the estrogenic activity of xenoestrogens.
    Kovalishyn VV; Kholodovych V; Tetko IV; Welsh WJ
    J Mol Graph Model; 2007 Sep; 26(2):591-4. PubMed ID: 17433745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line.
    Samuelsen M; Olsen C; Holme JA; Meussen-Elholm E; Bergmann A; Hongslo JK
    Cell Biol Toxicol; 2001; 17(3):139-51. PubMed ID: 11693576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular mechanism of bisphenol A (BPA) as an endocrine disruptor by interacting with nuclear receptors: insights from molecular dynamics (MD) simulations.
    Li L; Wang Q; Zhang Y; Niu Y; Yao X; Liu H
    PLoS One; 2015; 10(3):e0120330. PubMed ID: 25799048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
    Lill MA; Winiger F; Vedani A; Ernst B
    J Med Chem; 2005 Sep; 48(18):5666-74. PubMed ID: 16134935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
    Hagen ML; Hellmers M; Abrahamsen B; Hagen C
    Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
    [No Abstract]   [Full Text] [Related]  

  • 17. A docking modelling rationally predicts strong binding of bisphenol A to estrogen-related receptor gamma.
    Nose T; Shimohigashi Y
    Protein Pept Lett; 2008; 15(3):290-6. PubMed ID: 18336360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pathway of metabolic activation of bisphenol A-related compounds for estrogenic activity.
    Okuda K; Fukuuchi T; Takiguchi M; Yoshihara S
    Drug Metab Dispos; 2011 Sep; 39(9):1696-703. PubMed ID: 21636669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds.
    Kitamura S; Suzuki T; Sanoh S; Kohta R; Jinno N; Sugihara K; Yoshihara S; Fujimoto N; Watanabe H; Ohta S
    Toxicol Sci; 2005 Apr; 84(2):249-59. PubMed ID: 15635150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereo structure-controlled and electronic structure-controlled estrogen-like chemicals to design and develop non-estrogenic bisphenol A analogs based on chemical hardness concept.
    Kobayashi S; Shinohara H; Tabata K; Yamamoto N; Miyai A
    Chem Pharm Bull (Tokyo); 2006 Dec; 54(12):1633-8. PubMed ID: 17139095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.